Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Long-Term Deferred Tax (2016 - 2025)

Mimedx's Long-Term Deferred Tax history spans 6 years, with the latest figure at $19.6 million for Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax fell 30.77% year-over-year to $19.6 million; the TTM value through Dec 2025 reached $19.6 million, down 30.77%, while the annual FY2025 figure was $19.6 million, 30.77% down from the prior year.
  • Long-Term Deferred Tax for Q4 2025 was $19.6 million at Mimedx, down from $21.6 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $40.8 million in Q4 2023 and bottomed at $19.6 million in Q4 2025.
  • The 3-year median for Long-Term Deferred Tax is $28.3 million (2024), against an average of $29.8 million.
  • The largest YoY upside for Long-Term Deferred Tax was 18.07% in 2025 against a maximum downside of 30.77% in 2025.
  • A 3-year view of Long-Term Deferred Tax shows it stood at $40.8 million in 2023, then crashed by 30.58% to $28.3 million in 2024, then tumbled by 30.77% to $19.6 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Long-Term Deferred Tax are $19.6 million (Q4 2025), $21.6 million (Q3 2025), and $27.4 million (Q2 2025).